PR

Punita Rakesh Mehta

Active Director Director DIN 06685140
DIN 06685140 First appointment Sep 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2013
Shareholding value •••• Premium profile

About Punita Rakesh Mehta

Data last updated:

Punita Rakesh Mehta is a Director at Glester Pharmaceuticals Private Limited (since 2013). The company operates in Pharma. Glester Pharmaceuticals Private Limited reported revenue of ₹45 Lakh (FY 2024).

DIN 06685140
Primary Designation Director
Industry Pharma
First Appointment 10 Sep 2013
Oldest Company Age 13 yrs
Largest company Glester Pharmaceuticals Private Limited · ₹45 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Sep 20132012₹45 Lakh (FY 2024)Active

Board colleagues of Punita Rakesh Mehta

NameDINCompanyDesignation
Rakesh Niranjan Mehta06430865Glester Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Glester Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Punita Rakesh Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Punita Rakesh Mehta

Punita Rakesh Mehta currently holds 1 directorship: Glester Pharmaceuticals Private Limited (Director, since 10 Sep 2013, revenue ₹45 Lakh (FY 2024)).

Punita Rakesh Mehta was first appointed on 10 Sep 2013 as Director at Glester Pharmaceuticals Private Limited.

The current boards of Punita Rakesh Mehta's companies include Rakesh Niranjan Mehta (Glester Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available